REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., – May 16, 2022 – Kriya Therapeutics, Inc., a fully integrated gene ther...
SOUTH SAN FRANCISCO, Calif. and REDWOOD CITY, Calif. – March 09, 2022 – Twist Bioscience Corporation (NASDAQ: TWST), a compa...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — February 03, 2022 — Kriya Therapeutics, Inc., a fully integrated com...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., January 26, 2022 — Kriya Therapeutics, Inc., a fully integrated company...
Portfolio includes five investigational gene therapy programs for glycogen storage disorders that have no existing FDA-approved tr...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — December 20, 2021 — Kriya Therapeutics, Inc., a fully integrated comp...
– Dr. Heah brings extensive leadership and clinical experience to the company and will lead the new division’s overall strategy, clinical, regulatory and business development activities
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — July 28, 2021 — Kriya Therapeutics, Inc., a fully integrated platfor...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — July 14, 2021 — Kriya Therapeutics, Inc., a fully integrated platfor...
Kriya Therapeutics Strengthens Leadership Team with the Appointment of Dr. Ilise Lombardo as Chief Medical Officer So...